RegulatorySpineTop Stories

VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System

Tallahassee, FL – August 16, 2022 / OrthoSpineNews /VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its VyPlate Anterior Cervical Plate System. The VyPlate ACP system is indicated for stabilization of the anterior cervical spine from C2 to C7, employing unicortical screw fixation at the anterior face of the vertebral bodies.

The VyPlate ACP System features plates and screws manufactured from titanium alloy as specified by ASTM F-136. The system’s robust yet simple locking mechanism ensures that the bone screws are fully captured within the VyPlate.

“The VyPlate ACP System is a unique, elegantly simple system,” said Tom McLeer, CEO of VySpine. “It offers a great deal of versatility and flexibility while providing ease of use for the surgeon. The VyPlate is intuitive while also being robust and adaptable.”

The VyPlate ACP System is offered in numerous sizes, ranging from single level to five level plates. The VyPlate’s bone screws can either be variable (with a high degree of angulation), or in a fixed angle to the plate. Additionally, the VyPlate bone screws are available in self-drilling or self-tapping configurations. The screws come in a range of lengths and diameters to provide optimal fit with patient anatomy.

About VySpine

VySpine was created through active internal development and the licensing of various proven technologies using innovative materials and designs. This comprehensive line of core spine products and newly developed specialty products allow us to meet the needs of both health care providers and surgeons. The company strives to outpace the competition by collaborating with key spine innovators while providing a flexible, cost-effective approach to spine care. Learn more at

“VySpine” and “VyPlate” are registered trademarks of VySpine.

Media Contact: Paul Williams, 310-569-0023,

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button